Artgen Biotech PJSC (MOEX:ISKJ)

Artgen Biotech PJSC Balance Sheet

Financials in millions RUB. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	503.35	544.94	201.66	193.29	107.39
Trading Asset Securities	35.11	27.39	25.4	0.51	0.51
Cash & Short-Term Investments	538.46	572.33	227.06	193.8	107.9
Cash Growth	-5.92%	152.07%	17.16%	79.61%	-39.49%
Accounts Receivable	67.3	81.83	67.86	83.2	90.18
Other Receivables	52.33	72.58	61.69	23.92	41.98
Receivables	189.6	205.38	185.11	131.76	151.46
Inventory	246.84	226.31	223.87	245.79	233.54
Other Current Assets	97.94	113.22	53.74	86.71	83.04
Total Current Assets	1,073	1,117	689.77	658.06	575.93
Property, Plant & Equipment	376.86	315.87	280.51	285	330.25
Long-Term Investments	96.91	161.33	193.34	120.62	54.35
Other Intangible Assets	347.92	174.9	150.1	128.6	116.93
Long-Term Deferred Tax Assets	115.23	90.83	83.03	86.12	76.03
Long-Term Deferred Charges	510.21	631.35	586.62	414.09	342.11
Total Assets	2,671	2,544	2,045	1,737	1,512
Accounts Payable	54.92	53.41	33.87	35.94	35.38
Short-Term Debt	-	0.73	0.73	0.2	0.19
Current Portion of Long-Term Debt	87.71	219.72	106.44	-	177.77
Current Portion of Leases	25.17	19.53	11.69	8.89	9.91
Current Income Taxes Payable	15	24.84	24.57	14.61	10.7
Other Current Liabilities	286.11	243.16	218.28	312.52	322.18
Total Current Liabilities	468.91	561.4	395.57	372.15	556.13
Long-Term Debt	480.5	427.2	601.38	494.23	175
Long-Term Leases	144.28	119.77	111.36	113.82	125.59
Other Long-Term Liabilities	504.13	460.96	366	296.49	240.38
Total Liabilities	1,598	1,569	1,474	1,277	1,097
Common Stock	9.27	9.27	9.27	8.5	7.5
Additional Paid-In Capital	626.58	625.13	612.1	567.43	151.93
Retained Earnings	365.43	241.53	146.45	94.13	69.42
Treasury Stock	-499.39	-421.99	-447.85	-446.98	-34.97
Comprehensive Income & Other	-94.51	-30.06	21.07	11.7	0.38
Total Common Equity	407.37	423.87	341.04	234.78	194.26
Minority Interest	666.25	550.86	229.22	225.78	220.74
Shareholders' Equity	1,074	974.73	570.26	460.56	415
Total Liabilities & Equity	2,671	2,544	2,045	1,737	1,512
Total Debt	737.65	786.96	831.6	617.13	488.46
Net Cash (Debt)	-199.2	-214.62	-604.55	-423.33	-380.56
Net Cash Per Share	-2.15	-2.32	-6.96	-5.29	-5.07
Filing Date Shares Outstanding	73.76	75.15	81.61	85	75
Total Common Shares Outstanding	73.76	75.15	81.61	85	75
Working Capital	603.94	555.84	294.2	285.9	19.81
Book Value Per Share	5.52	5.64	4.18	2.76	2.59
Tangible Book Value	59.45	248.97	190.94	106.18	77.33
Tangible Book Value Per Share	0.81	3.31	2.34	1.25	1.03
Buildings	63.02	67.06	49.65	97.89	94.08
Machinery	419.13	375.42	353.72	336.45	325.07
Construction In Progress	16.15	-	-	0.05	0.9

Updated Sep 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.